{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:45:58Z","timestamp":1787697958057,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ejogrb.2005.09.007","type":"journal-article","created":{"date-parts":[[2005,10,24]],"date-time":"2005-10-24T14:12:38Z","timestamp":1130163158000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia"],"prefix":"10.1016","volume":"127","author":[{"given":"Eva Maria","family":"Roes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten T.","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo M. de","family":"Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra L.","family":"Zusterzeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans M.","family":"Merkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert H.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Steegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2005.09.007_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9378(85)80171-X","article-title":"Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester","volume":"152","author":"Sibai","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","article-title":"Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks\u2019 gestation: a randomized controlled trial","volume":"171","author":"Sibai","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib3","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28\u201334 weeks\u2019 gestation: a randomized controlled trial","volume":"76","author":"Odendaal","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1016254","article-title":"Oxidative stress and altered endothelial cell function in preeclampsia","volume":"16","author":"Davidge","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-1016256","article-title":"Maternal\u2013placental interactions of oxidative stress and antioxidants in preeclampsia","volume":"16","author":"Walsh","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0002-9378(94)90462-6","article-title":"Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia","volume":"171","author":"Mikhail","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib7","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/0002-9378(91)90018-M","article-title":"Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension","volume":"165","author":"Wisdom","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib8","first-page":"1012","article-title":"Low whole blood glutathione levels in pregnancies complicated by preeclampsia or the hemolysis, elevated liver enzymes, low platelets syndrome","volume":"92","author":"Knapen","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000009994","article-title":"Imbalance between lipid peroxidation and antioxidant status in preeclampsia","volume":"46","author":"Mutlu Turkoglu","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib10","first-page":"180","article-title":"Plasma thiol status in preeclampsia","volume":"95","author":"Raijmakers","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib11","first-page":"272","article-title":"Oxidized and free whole blood thiols in preeclampsia","volume":"97","author":"Raijmakers","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-4887.1996.tb03770.x","article-title":"Biological chemistry of thiols in the vasculature and in vascular-related disease","volume":"54","author":"Stamler","year":"1996","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1981.00340030112020","article-title":"Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment","volume":"141","author":"Rumack","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0891-5849(97)00059-2","article-title":"The effects of intravenous antioxidants in patients with septic shock","volume":"23","author":"Galley","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.112.1.164","article-title":"A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group","volume":"112","author":"Bernard","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002280050140","article-title":"Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial","volume":"50","author":"Akerlund","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00003246-199906000-00028","article-title":"N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study","volume":"27","author":"Molnar","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0609.1996.tb01370.x","article-title":"Red blood cell permeability to thiol compounds following oxidative stress","volume":"57","author":"Mazor","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1054\/mehy.2000.1079","article-title":"Deficient detoxifying capacity in the pathophysiology of preeclampsia","volume":"55","author":"Roes","year":"2000","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","article-title":"The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib23","unstructured":"Conover WJ. In: Conover WJ, editor. New York: Wiley & Sons; 1980. p. 223\u201327."},{"key":"10.1016\/j.ejogrb.2005.09.007_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1471-0528.1997.tb11979.x","article-title":"Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial","volume":"104","author":"Gulmezoglu","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000292570","article-title":"Vitamin E supplementation in preeclampsia","volume":"37","author":"Stratta","year":"1994","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/CCLM.2002.086","article-title":"Effects of oral N-acetylcysteine on plasma homocysteine and whole blood glutathione levels in healthy, non-pregnant females","volume":"40","author":"Roes","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0021-9150(95)05635-1","article-title":"N-Acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels","volume":"119","author":"Wiklund","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib29","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1016\/S0021-9258(19)77815-6","article-title":"Glutathione metabolism and its selective modification","volume":"263","author":"Meister","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0891-5849(96)00554-0","article-title":"Blood glutathione as an index of radiation-induced oxidative stress in mice and humans","volume":"22","author":"Navarro","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/BF00558131","article-title":"The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage","volume":"37","author":"Prescott","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib32","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1016\/0002-9343(91)90296-A","article-title":"Use of N-acetylcysteine in clinical toxicology","volume":"91","author":"Flanagan","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib34","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/0002-9378(95)91412-9","article-title":"Neonatal outcome after preterm delivery for preeclampsia","volume":"172","author":"Friedman","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/15563659709001226","article-title":"Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity","volume":"35","author":"Horowitz","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0196-0644(05)81354-X","article-title":"Transplacental transport of N-acetylcysteine in an ovine model","volume":"20","author":"Selden","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ejogrb.2005.09.007_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s002280050687","article-title":"Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants","volume":"55","author":"Ahola","year":"1999","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505005038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505005038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:27Z","timestamp":1759554927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505005038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0301211505005038"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.09.007","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}